BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32500979)

  • 21. Growing consumption of antibiotics and epidemiology of Clostridioides difficile infections in Poland: A need to develop new solutions.
    Jachowicz E; Pobiega M; Różańska A; Wójkowska-Mach J
    Acta Microbiol Immunol Hung; 2020 Jun; 67(2):79-86. PubMed ID: 31813263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Certain Rooms in Intensive Care Units May Harbor Risk for
    Danehower S; Lazorko J; Kaplan LJ; Fegley M; Jablonski J; Owei L; Ziegler MJ; Pisa M; Pegues D; Pascual JL
    Surg Infect (Larchmt); 2022 Mar; 23(2):159-167. PubMed ID: 35020481
    [No Abstract]   [Full Text] [Related]  

  • 23. Decreasing ICU-associated
    Safdar N; Parmasad V; Brown R; Carayon P; Lepak A; O'Horo JC; Schulz L
    BMJ Open; 2021 Jun; 11(6):e046480. PubMed ID: 34187821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D; Young LR; Reddy S; Bergman C; Young JD
    J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Healthcare-associated Clostridium difficile infection: role of correct hand hygiene in cross-infection control.
    Ragusa R; Giorgianni G; Lupo L; Sciacca A; Rametta S; La Verde M; Mulè S; Marranzano M
    J Prev Med Hyg; 2018 Jun; 59(2):E145-E152. PubMed ID: 30083622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.
    Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D
    Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
    Daniel A; Rapose A
    J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perils and pitfalls of probiotic quasi-experimental studies for primary prevention of Clostridioides difficile infection: A review of the evidence.
    McFarland LV; Johnson SB; Evans CT
    Am J Infect Control; 2021 Mar; 49(3):375-384. PubMed ID: 32791261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reducing Recurrence and Complications Related to Clostridioides difficile Infection: A Panel Discussion Summary.
    Perez R; Khanna S; Tillotson GS; Lett JE; Prince MA; Lattimer C
    Prof Case Manag; 2022 Nov-Dec 01; 27(6):277-287. PubMed ID: 36206121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors and intestinal microbiota: Clostridioides difficile infection in patients receiving enteral nutrition at Intensive Care Units.
    Wang D; Dong D; Wang C; Cui Y; Jiang C; Ni Q; Su T; Wang G; Mao E; Peng Y
    Crit Care; 2020 Jul; 24(1):426. PubMed ID: 32660525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of patients at risk of Clostridioides difficile infection for enrollment in vaccine clinical trials.
    Stevens VW; Russo EM; Young-Xu Y; Leecaster M; Zhang Y; Zhang C; Yu H; Cai B; Gonzalez EN; Gerding DN; Lawrence J; Samore MH
    Vaccine; 2021 Jan; 39(3):536-544. PubMed ID: 33334614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementation of Global Strategies to Prevent Hospital-Onset Clostridium difficile Infection: Targeting Proton Pump Inhibitors and Probiotics.
    Lewis PO; Lundberg TS; Tharp JL; Runnels CW
    Ann Pharmacother; 2017 Oct; 51(10):848-854. PubMed ID: 28821215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hand hygiene as the basic method of reducing
    Kiersnowska ZM; Lemiech-Mirowska E; Michałkiewicz M; Marczak M
    Ann Agric Environ Med; 2021 Dec; 28(4):535-540. PubMed ID: 34969208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea.
    Abad CLR; Safdar N
    Gastroenterol Clin North Am; 2021 Jun; 50(2):323-340. PubMed ID: 34024444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic and infection control strategies for Clostridioides difficile infections in a setting of high antimicrobial resistance prevalence.
    Bertolino L; Patauner F; Gagliardi M; D'Amico F; Crivaro V; Bernardo M; Scherillo I; Bellitti F; Cusano C; Greco R; Panetta V; Durante A; Di Caterino A; Frieri A; Cioffi G; Nappo M; Corrado M; Lanzieri M; Sabatini P; Bettelli R; Dello Russo R; Taddeo ML; Petrone R; Di Sevo MG; Iannuzzo M; Iervolino M; Buonocore R; D'Agostino F; Gambardella M; De Martino A; Spagnuolo S; Savarese M; Sole S; Russo C; Agozzino E; Galdiero M; Martino R; Calemma R; Sciambra A; Aprea C; Colaccio D; Di Guida P; Venditti M; Montella E; Guerriero F; Perrotta R; Di Filippo U; Pizza A; Di Fronzo A; Lombardi A; Capuano L; De Stefano A; Mastropietro A; Mastro M; Loffreda R; Maccarone L; Di Tora A; Oto S; Tammaro C; Mondelli AC; Ruocco M; Ferraro B; Petrosino A; Presta SSA; Durante Mangoni E
    Infez Med; 2021 Mar; 29(1):70-78. PubMed ID: 33664175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between remote cholecystectomy and incident Clostridioides difficile infection.
    Wang Y; Li J; Zachariah P; Abrams J; Freedberg DE
    Clin Microbiol Infect; 2019 Aug; 25(8):994-999. PubMed ID: 30583059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
    Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
    [No Abstract]   [Full Text] [Related]  

  • 38. Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.
    Faleck DM; Salmasian H; Furuya EY; Larson EL; Abrams JA; Freedberg DE
    Am J Gastroenterol; 2016 Nov; 111(11):1641-1648. PubMed ID: 27575714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
    Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
    World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.
    Stevens V; Dumyati G; Brown J; Wijngaarden E
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1035-42. PubMed ID: 21833992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.